Earningsreport

Q3/2019 9/30/2019 EPS -0.040 ZacksConsensus -0.040 ActVsEst 0.000 - In-Line

Actinium Pharmaceuticals, Inc. (Delaware)  (ATNM) 
NASDAQ:AMEX Investor Relations: ir.actiniumpharma.com